Detection Technology (DETEC) Q4 2024 earnings summary

Executive summary

• Q4 sales reached EUR 31.6 million, up 0.9% year-over-year, with EBITDA/EBITA at EUR 5.2 million (16.3% margin); full-year sales were EUR 107.5 million, up 3.6%, with EBITDA/EBITA of EUR 14.9 million (13.9% margin), and net profit and EPS doubled year-over-year.

• Security became the largest segment, accounting for 44% of Q4 sales and 43% for the full year.

• Strong cash flow from operations reached EUR 20.1 million for the year, supporting financial resilience and a record dividend proposal.

• Board proposes a dividend of EUR 0.50 per share (66% payout ratio), totaling EUR 7.3 million.

• Regional reorganization effective January 2024/2025, with APAC, EMEA, and Americas operating as independent business units.

Financial highlights

• Q4 EBITDA/EBITA margin improved to 16.3% (from less than 15%); full-year margin rose to 13.9% (from 8.5%).

• Earnings per share for the year reached EUR 0.76 (up from 0.38).

• R&D costs were stable at about 10.6% of sales, totaling EUR 11.4 million.

• Investments for the year totaled EUR 2.2 million, mainly in production and measuring equipment.

• Return on investment for the year was 17.4%.

Outlook and guidance

• Q1 2024/2025 expected to be flat, with double-digit sales growth anticipated from Q2 as medical sales recover.

• Full-year/medium-term targets: 10%+ sales growth and 15% EBITDA/EBITA margin.

• Security sales to decline in Q1 due to inventory corrections or airport construction delays, with growth resuming in Q2.

• Geopolitical risks, tariffs, and global economic uncertainty may impact performance.